Exacerbation of psoriasis with GM-CSF therapy.

Suppr

超能文献

作者信息

Kelly R, Marsden R A, Bevan D

出版信息

Br J Dermatol. 1993 Apr;128(4):468-9. doi: 10.1111/j.1365-2133.1993.tb00218.x.

DOI:10.1111/j.1365-2133.1993.tb00218.x

PMID:8494766

Abstract

摘要

相似文献

Exacerbation of psoriasis with GM-CSF therapy.

Br J Dermatol. 1993 Apr;128(4):468-9. doi: 10.1111/j.1365-2133.1993.tb00218.x.

Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.

J Korean Med Sci. 1998 Dec;13(6):685-8. doi: 10.3346/jkms.1998.13.6.685.

Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes.

Br J Haematol. 1991 Mar;77(3):291-5. doi: 10.1111/j.1365-2141.1991.tb08573.x.

Colony-stimulating factor and macrophage proliferation.

Am J Clin Pathol. 1994 Jan;101(1):116-7.

Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.

Exp Hematol. 1992 Jun;20(5):558-64.

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.

J Clin Oncol. 1996 Jan;14(1):277-86. doi: 10.1200/JCO.1996.14.1.277.

GM-CSF treatment and hypokalemia.

Ann Intern Med. 1989 Aug 1;111(3):263. doi: 10.7326/0003-4819-111-3-263_1.

[Combined GM-CSF and erythropoietin therapy in myelodysplastic syndrome].

Schweiz Med Wochenschr. 1989 Dec 9;119(49):1777-80.

Clinical toxicity of cytokines used as haemopoietic growth factors.

Drug Saf. 1995 Dec;13(6):371-406. doi: 10.2165/00002018-199513060-00006.

Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.

J Clin Oncol. 1999 Apr;17(4):1296. doi: 10.1200/JCO.1999.17.4.1296.

引用本文的文献

Experimental Pharmacological Management of Psoriasis.

J Exp Pharmacol. 2021 Jul 26;13:725-737. doi: 10.2147/JEP.S265632. eCollection 2021.

Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update.

Front Immunol. 2019 Jun 4;10:1265. doi: 10.3389/fimmu.2019.01265. eCollection 2019.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti-GM-CSF monoclonal antibody.

Br J Dermatol. 2019 Jun;180(6):1352-1360. doi: 10.1111/bjd.17195. Epub 2018 Nov 2.

GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency.

PLoS One. 2017 Aug 4;12(8):e0182646. doi: 10.1371/journal.pone.0182646. eCollection 2017.

Integrated network analysis of transcriptomic and proteomic data in psoriasis.

BMC Syst Biol. 2010 Apr 8;4:41. doi: 10.1186/1752-0509-4-41.

Drug-induced vasculitis.

Curr Rheumatol Rep. 2002 Feb;4(1):55-9. doi: 10.1007/s11926-002-0024-y.

Recognition and treatment of psoriasis. Special considerations in elderly patients.

Drugs Aging. 1998 Mar;12(3):177-90. doi: 10.2165/00002512-199812030-00002.

Clinical toxicity of cytokines used as haemopoietic growth factors.

Drug Saf. 1995 Dec;13(6):371-406. doi: 10.2165/00002018-199513060-00006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验